Chemed Corporation (CHE)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
VITAS Revenue	1.62B	1.53B	1.32B
VITAS Revenue Growth	5.97%	16.42%	9.45%
Roto-Rooter Revenue	908.28M	900.31M	949.35M
Roto-Rooter Revenue Growth	0.89%	-5.17%	1.71%
Revenue (Total)	2.53B	2.43B	2.26B
Revenue (Total) Growth	4.09%	7.37%	6.06%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
VITAS Income From Operations	249.76M	263.97M	184.10M
VITAS Income From Operations Growth	-5.38%	43.39%	18.68%
Roto-Rooter Income From Operations	174.22M	194.52M	226.76M
Roto-Rooter Income From Operations Growth	-10.44%	-14.22%	-3.80%
Corporate Income From Operations	-72.50M	-91.99M	-70.29M
Operating Income (Total)	351.47M	366.49M	340.57M
Operating Income (Total) Growth	-4.10%	7.61%	-0.85%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
VITAS Adjusted EBITDA	273.44M	285.54M	204.39M
VITAS Adjusted EBITDA Growth	-4.24%	39.70%	12.30%
Roto-Rooter Adjusted EBITDA	217.47M	237.09M	269.57M
Roto-Rooter Adjusted EBITDA Growth	-8.28%	-12.05%	-1.53%
Corporate Adjusted EBITDA	-19.34M	-19.62M	-22.06M
Operating Income (Other)	-120.09M	-136.51M	-111.33M
Operating Income (Total)	351.47M	366.49M	340.57M
Operating Income (Total) Growth	-4.10%	7.61%	-0.85%

Net Income

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
VITAS Net Income	205.13M	216.82M	158.51M
VITAS Net Income Growth	-5.39%	36.79%	20.58%
Roto-Rooter Net Income	144.65M	160.05M	188.24M
Roto-Rooter Net Income Growth	-9.62%	-14.98%	1.14%
Corporate Net Income	-70.98M	-74.87M	-74.24M

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Total Average Daily Census (ADC) (Days)	-	21.17K	18.61K
Total Average Daily Census (ADC) (Days) Growth	-	13.74%	7.43%
Total Admissions	69.83K	67.45K	63.43K
Total Admissions Growth	3.53%	6.33%	4.37%
Total Discharges	69.26K	64.62K	61.24K
Total Discharges Growth	7.19%	5.51%	0.51%
Average Length of Stay (Days)	-	103.00	102.20
Average Length of Stay (Days) Growth	-	0.78%	-2.29%
Median Length of Stay (Days)	-	17.00	16.00
Median Length of Stay (Days) Growth	-	6.25%	-

Updated Oct 28, 2025. Data Source: Fiscal.ai.